IXICO PLC

LSE:IXI UK Biotechnology
Market Cap
$87.95K
GBX722.82 Million GBX
Market Cap Rank
#48165 Global
#1146 in UK
Share Price
GBX7.80
Change (1 day)
+0.00%
52-Week Range
GBX7.63 - GBX14.00
All Time High
GBX123.50
Categories
Companies in UK Biotechnology
About

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imag… Read more

IXICO PLC (IXI) - Net Assets

Latest net assets as of September 2025: GBX11.74 Million GBX

Based on the latest financial reports, IXICO PLC (IXI) has net assets worth GBX11.74 Million GBX as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX13.84 Million) and total liabilities (GBX2.10 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX11.74 Million
% of Total Assets 84.81%
Annual Growth Rate N/A
5-Year Change 2.25%
10-Year Change 187.32%
Growth Volatility 135.7

IXICO PLC - Net Assets Trend (1993–2025)

This chart illustrates how IXICO PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for IXICO PLC (1993–2025)

The table below shows the annual net assets of IXICO PLC from 1993 to 2025.

Year Net Assets Change
2025-09-30 GBX11.74 Million +24.02%
2024-09-30 GBX9.46 Million -17.21%
2023-09-30 GBX11.43 Million -8.49%
2022-09-30 GBX12.49 Million +8.83%
2021-09-30 GBX11.48 Million +25.88%
2020-09-30 GBX9.12 Million +15.15%
2019-09-30 GBX7.92 Million +8.09%
2018-09-30 GBX7.33 Million +172.44%
2017-09-30 GBX2.69 Million -34.17%
2016-09-30 GBX4.08 Million +50.79%
2015-09-30 GBX2.71 Million -28.93%
2014-09-30 GBX3.81 Million +6.15%
2013-09-30 GBX3.59 Million -57.12%
2012-09-30 GBX8.37 Million -47.55%
2011-09-30 GBX15.96 Million -32.00%
2010-09-30 GBX23.48 Million +648.42%
2009-09-30 GBX3.14 Million -56.19%
2008-09-30 GBX7.16 Million +155.66%
2007-09-30 GBX2.80 Million -56.77%
2006-08-31 GBX6.48 Million -45.16%
2005-08-31 GBX11.81 Million +123.24%
2004-08-31 GBX5.29 Million +3.83%
2003-08-31 GBX5.10 Million -50.44%
2002-08-31 GBX10.29 Million -21.44%
2001-08-31 GBX13.09 Million +175.04%
2000-08-31 GBX4.76 Million +131.07%
1999-08-31 GBX2.06 Million -30.26%
1998-08-31 GBX2.95 Million -54.40%
1997-08-31 GBX6.48 Million -32.12%
1996-08-31 GBX9.54 Million +478.69%
1995-08-31 GBX-2.52 Million +6.98%
1994-08-31 GBX-2.71 Million -429.10%
1993-08-31 GBX-512.00K --

Equity Component Analysis

This analysis shows how different components contribute to IXICO PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 8359600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2025)

Component Amount Percentage
Common Stock GBX927.00K 7.90%
Other Comprehensive Income GBX7.36 Million 62.70%
Other Components GBX88.06 Million 750.24%
Total Equity GBX11.74 Million 100.00%

IXICO PLC Competitors by Market Cap

The table below lists competitors of IXICO PLC ranked by their market capitalization.

Company Market Cap
Millennium Investment & Acquisition Company Inc
PINK:MILC
 		$988.99
Universal Global Hub Inc
PINK:UGHB
 		$989.05
BORDERS & SOUTH PET
BE:B5T
 		$989.74
SCS
WAR:SCS
 		$990.09
Blackrock World Mining Trust Plc
LSE:BRWM
 		$986.41
Henderson Smaller Cos Inv Tst
LSE:HSL
 		$985.77
Pure Broadcast Corp
PINK:PCST
 		$982.62
INDOSAT -B-
MU:IDO1
 		$982.10

Equity Growth Attribution

This analysis shows how different factors contributed to changes in IXICO PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 9,464,000 to 11,737,000, a change of 2,273,000 (24.0%).
  • Net loss of 1,651,000 reduced equity.
  • New share issuances of 3,697,000 increased equity.
  • Other factors increased equity by 227,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX-1.65 Million -14.07%
Share Issuances GBX3.70 Million +31.5%
Other Changes GBX227.00K +1.93%
Total Change GBX- 24.02%

Book Value vs Market Value Analysis

This analysis compares IXICO PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 59.46x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1993-08-31 GBX-0.91 GBX7.80 x
1994-08-31 GBX-4.83 GBX7.80 x
1995-08-31 GBX-4.49 GBX7.80 x
1996-08-31 GBX15.74 GBX7.80 x
1997-08-31 GBX7.69 GBX7.80 x
1998-08-31 GBX3.48 GBX7.80 x
1999-08-31 GBX2.32 GBX7.80 x
2000-08-31 GBX5.00 GBX7.80 x
2001-08-31 GBX12.76 GBX7.80 x
2002-08-31 GBX9.76 GBX7.80 x
2003-08-31 GBX4.82 GBX7.80 x
2004-08-31 GBX4.75 GBX7.80 x
2005-08-31 GBX8.46 GBX7.80 x
2006-08-31 GBX4.64 GBX7.80 x
2007-09-30 GBX1.92 GBX7.80 x
2008-09-30 GBX3.52 GBX7.80 x
2009-09-30 GBX1.23 GBX7.80 x
2010-09-30 GBX4.13 GBX7.80 x
2011-09-30 GBX2.30 GBX7.80 x
2012-09-30 GBX1.21 GBX7.80 x
2013-09-30 GBX0.52 GBX7.80 x
2014-09-30 GBX0.25 GBX7.80 x
2015-09-30 GBX0.18 GBX7.80 x
2016-09-30 GBX0.17 GBX7.80 x
2017-09-30 GBX0.10 GBX7.80 x
2018-09-30 GBX0.22 GBX7.80 x
2019-09-30 GBX0.17 GBX7.80 x
2020-09-30 GBX0.19 GBX7.80 x
2021-09-30 GBX0.23 GBX7.80 x
2022-09-30 GBX0.25 GBX7.80 x
2023-09-30 GBX0.24 GBX7.80 x
2024-09-30 GBX0.20 GBX7.80 x
2025-09-30 GBX0.13 GBX7.80 x

Capital Efficiency Dashboard

This dashboard shows how efficiently IXICO PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -14.07%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -25.27%
  • • Asset Turnover: 0.47x
  • • Equity Multiplier: 1.18x
  • Recent ROE (-14.07%) is above the historical average (-49.60%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1993 0.00% -238.41% 0.67x 0.00x GBX-668.80K
1994 0.00% -1639.55% 0.71x 0.00x GBX-1.93 Million
1995 0.00% 16.97% 3.29x 0.00x GBX441.00K
1996 -5.92% -60.49% 0.09x 1.04x GBX-1.52 Million
1997 -47.31% -6811.11% 0.01x 1.12x GBX-3.71 Million
1998 -123.02% -509.68% 0.19x 1.26x GBX-3.93 Million
1999 -156.36% -131.63% 0.76x 1.55x GBX-3.43 Million
2000 -45.86% -105.05% 0.36x 1.20x GBX-2.66 Million
2001 -20.26% -180.35% 0.10x 1.08x GBX-3.96 Million
2002 -31.94% -121.04% 0.22x 1.19x GBX-4.31 Million
2003 -104.04% -218.50% 0.35x 1.36x GBX-5.81 Million
2004 -117.65% -580.78% 0.14x 1.43x GBX-6.76 Million
2005 -28.15% -45.08% 0.52x 1.19x GBX-4.51 Million
2006 -87.04% -299.47% 0.23x 1.27x GBX-6.29 Million
2007 -207.56% -186.25% 0.75x 1.48x GBX-6.09 Million
2008 -31.77% -86.73% 0.31x 1.19x GBX-2.99 Million
2009 -124.67% -451.10% 0.18x 1.56x GBX-4.22 Million
2010 -16.19% -545.48% 0.03x 1.05x GBX-6.15 Million
2011 -47.97% -11429.85% 0.00x 1.16x GBX-9.25 Million
2012 -92.75% -41493.34% 0.00x 1.26x GBX-8.60 Million
2013 -132.75% -47670.00% 0.00x 1.43x GBX-5.13 Million
2014 -45.09% -67.15% 0.47x 1.42x GBX-2.10 Million
2015 -44.08% -38.33% 0.73x 1.56x GBX-1.46 Million
2016 -51.87% -64.84% 0.58x 1.39x GBX-2.53 Million
2017 -57.16% -37.49% 0.91x 1.68x GBX-1.81 Million
2018 -9.12% -12.38% 0.52x 1.41x GBX-1.40 Million
2019 5.46% 5.71% 0.71x 1.35x GBX-359.90K
2020 10.44% 9.99% 0.79x 1.33x GBX40.10K
2021 13.17% 16.45% 0.64x 1.24x GBX364.10K
2022 8.26% 11.94% 0.59x 1.17x GBX-217.30K
2023 -10.30% -17.67% 0.51x 1.14x GBX-2.32 Million
2024 -21.14% -34.70% 0.52x 1.18x GBX-2.95 Million
2025 -14.07% -25.27% 0.47x 1.18x GBX-2.82 Million

Industry Comparison

This section compares IXICO PLC's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $10,807,025
  • Average return on equity (ROE) among peers: -134.93%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
IXICO PLC (IXI) GBX11.74 Million 0.00% 0.18x $986.57
4BASEBIO UK SOCIETAS (4BB) $11.70 Million -27.66% 0.26x $10.53K
Aptamer Group PLC (APTA) $8.05 Million -26.00% 0.43x $3.12K
Arecor Therapeutics PLC (AREC) $773.79K -355.70% 4.54x $3.33K
Bioventix (BVXP) $4.20 Million 36.18% 0.07x $9.85K
Cizzle Biotechnology Holdings PLC (CIZ) $741.00K -0.02% 3.16x $747.56
Fusion Antibodies PLC (FAB) $1.46 Million 79.21% 0.28x $2.07K
Faron Pharmaceuticals Oy (FARN) $1.61 Million -823.73% 5.34x $27.00K
Futura Medical (FUM) $9.72 Million -50.98% 0.21x $424.60
hVIVO plc (HVO) $2.86 Million -195.31% 2.17x $5.18K
International Biotechnology Trust plc (IBT) $66.95 Million 14.71% 0.00x $997.94